Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective.

Simpson, E.L., Davis, S., Thokala, P. et al. (3 more authors) (2015) Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. Pharmacoeconomics.

Abstract

Metadata

Authors/Creators:
  • Simpson, E.L.
  • Davis, S.
  • Thokala, P.
  • Breeze, P.R.
  • Bryden, P.
  • Wong, R.
Copyright, Publisher and Additional Information: © Springer International Publishing Switzerland 2015. This is an author produced version of a paper subsequently published in PharmacoEconomics. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: 29 May 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 03 Jun 2015 16:08
Last Modified: 02 Jul 2017 06:53
Published Version: https://dx.doi.org/10.1007/s40273-015-0296-5
Status: Published
Publisher: Springer
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-015-0296-5
Related URLs:

Export

Statistics